We report the results of endovascular treatment of Trans-Atlantic Inter-Society Consensus II (TASC) A&B, TASC C, and TASC D aortoiliac lesions in a single vascular center. In this retrospective, observational cohort study, we analyzed 395 patients (mean age 61.2 ± 9.0; 359 men) between January 2015 and December 2017. Technical success was achieved in 96.5%; in-hospital mortality was 1.2% (n = 5). Median follow-up was 36 months (range 24-49 months). After 1 and 5 years, the primary patency rates were 99% and 85% for TASC A&B, 90%, and 78% for TASC C, and 90% and 74% for TASC D. Secondary patency rates were 99% and 90% for TASC A&B, 98% and 65% for TASC C, and 97% and 65% for TASC D. Previous peripheral revascularization (hazard ratio: 1.76, 95% CI: 1.01-3.08, P = .04) was associated with decreased primary patency along with lower age, TASC C, and TASC D class. This analysis reported the acceptable effectiveness and safety of stenting for all types of aortoiliac occlusive disease in a modern setting, with few complications and excellent long-term primary and secondary patency rates.
NorgrenLHiattWRDormandyJA, et al.TASCII working group. Inter-Society consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1–75.
2.
SixtSKrankenbergHMöhrleC, et al.Endovascular treatment for extensive aortoiliac artery reconstruction: a single-center experience based on 1712 interventions. J Endovasc Ther. 2013;20:64–73.
3.
de DonatoGBosiersMSetacciF, et al.24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions. Ann Vasc Surg. 2015;29:738–50.
4.
PiffarettiGFargionATDorigoW, et al.Outcomes from the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease. J Endovasc Ther. 2019;26:623–32.
5.
IndesJEPfaffMJFarrokhyarF, et al.Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther. 2013;20:443–55.
6.
DorigoWPiffarettiGBenedettoF, et al.A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. J Vasc Surg. 2017;65:99–107.
7.
HajibandehSHajibandehSAntoniouSA, et al.Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis. J Endovasc Ther. 2016;23:442–52.
8.
StonerMCCalligaroKDChaerRA, et al.Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64:e1–21.
9.
AboyansVRiccoJBBartelinkMEL, et al.Editor’s choice: 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:305–68.
10.
RutherfordRBBakerJDErnstC, et al.Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–38.
11.
ShrikhandeGVGrahamARAparajitaR, et al.Determining criteria for predicting stenosis with ultrasound duplex after endovascular intervention in infrainguinal lesions. Ann Vasc Surg2011;25:454–60.
12.
David Firth. Bias Reduction of Maximum Likelihood Estimates. Biometrika. 1993;80:27–38.
13.
HeinzeGSchemperM. Solution to the problem of monotone likelihood in Cox regression. Biometrics. 2001;57:114–9.
14.
LinLHedayatASWuW. A unified approach for assessing agreement for continuous and categorical data. J Biopharm Stat. 2007;17:629–52.
15.
ConteMSPomposelliFBClairDG, et al.Society for Vascular Surgery. Society for Vascular Surgery Practice Guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61:2S–41S.
16.
De VriesSHuninkM. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg. 1997;26:558–69.
17.
SuzukiKMizutaniYSogaY, et al.Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions. Angiology. 2017;68:67–73.
18.
YeWLiuC-WRiccoJ-B, et al.Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg. 2011;53:1728–37.
19.
FarooqVvan KlaverenDSteyerbergEW, et al.Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639–50.
20.
DormandyJARutherfordRB. Management of peripheral arterial disease (PAD). TASC Working Group. Trans-Atlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–296.
21.
SogaYIidaOKawasakiD, et al.Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J. 2012;76:2697–704.
22.
HessCNHuangZPatelMR, et al.Acute Limb Ischemia in Peripheral Artery Disease: Insights from EUCLID. Circulation. 2019;140:556–65.
23.
ValentineRJJacksonMRModrallJG, et al.The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service. J Vasc Surg. 1999;30:436–45.
24.
ReedABConteMSDonaldsonMC, et al.The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg. 2003;37:1219–25.
25.
RoachANLarionSAhanchiSS, et al.The effect of demographic factors and lesion severity on iliac stent patency. J Vasc Surg. 2015;62:645–53.
